Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. (Q37023177)
Jump to navigation
Jump to search
scientific article published on January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. |
scientific article published on January 2009 |
Statements
1 reference
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. (English)
1 reference
Margaret von Mehren
1 reference
Burton L Eisenberg
1 reference
Jonathan Harris
1 reference
Charles D Blanke
1 reference
George D Demetri
1 reference
Michael C Heinrich
1 reference
James C Watson
1 reference
John P Hoffman
1 reference
Scott Okuno
1 reference
John M Kane
1 reference
1 January 2009
1 reference
1 reference
42-47
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference